Crossmark

Development and Evaluation of a PH-Responsive Bovine Serum Albumin-Functionalized Layered Double Hydroxide Nanocarrier for Targeted Therapy of Ovarian Cancer

Crossref DOI link: https://doi.org/10.1007/s12247-025-10104-6

Published Online: 2025-09-22

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ibrahim, Mervat Shafik

Elsayyad, Nihal Mohamed Elmahdy

Noshi, Shereen H.
Funding

Funding for this research was provided by:

October University for Modern Sciences and Arts
License Information

Text and Data Mining valid from 2025-09-22

Version of Record valid from 2025-09-22
More Information

Article History

Received: 24 May 2025

Accepted: 3 September 2025

First Online: 22 September 2025

Declarations

:

: The MSA research and ethics committee approved all the procedures conducted in this study (application number PT7/Ec7/2022F).

: During the preparation of this work, the author(s) used ChatGPT 3.5 to improve the readability and language of the manuscript. After using this tool/service, the author(s) reviewed and edited the content as needed and take full responsibility for the content of the published article.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below